Dr. Parsons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1470 Madison Avenue
New York, NY 10029Phone+1 212-824-9331
Education & Training
- Stony Brook University Health Sciences Center School of MedicineClass of 1992, MD
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
Publications & Presentations
PubMed
- 6999 citationsWAF1, a potential mediator of p53 tumor suppressionWafik S. El-Deiry, Takashi Tokino, Victor E. Velculescu, Daniel B. Levy, Ramon Parsons
Cell. 1993-11-19 - 501 citationsAn inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− miceKatrina Podsypanina, Richard T. Lee, Chris Politis, Ian Hennessy, Allison Crane
Proceedings of the National Academy of Sciences of the United States of America. 2001-08-28 - 3896 citationsPTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerJing Li, Clifford Yen, Danny Liaw, Katrina Podsypanina, Shikha Bose
Science. 1997-03-28
Journal Articles
- Mouse ER+/PIK3CAH1047R Breast Cancers Caused by Exogenous Estrogen Are Heterogeneously Dependent on Estrogen and Undergo BIM-Dependent Apoptosis with BH3 and PI3K AgentsMatthias Szabolcs, Ramon Parsons, Hank Schmidt, Nature
Press Mentions
- Two Renowned Cancer Experts to Head New Tisch Cancer Hospital at the Mount Sinai HospitalMarch 15th, 2023
- Newly Developed Therapeutic Agent Can Be Effective for Various Cancer TypesJanuary 26th, 2023
- New Gene Essential to Colon Cancer Growth IdentifiedOctober 18th, 2022
- Join now to see all
Grant Support
- Mutual Regulation Of PTEN And P-Rex2a In Normal And Cancer CellsNational Cancer Institute2011–2012
- Oncogenic Role Of PIK3CA Hotspot MutationsNational Cancer Institute2009–2012
- The Role Of PTEN In Basal-Like Breast CancerNational Cancer Institute2011
- Administrative And Analytical CoreNational Cancer Institute2011
- Molecular Pathogenesis Of Basal-Like Breast CancerNational Cancer Institute2009–2011
- Breast Cancer ResearchNational Cancer Institute2008–2011
- PTEN Tumor Suppressor And Signal TransductionNational Cancer Institute2001–2010
- PI-3 Kinase Therapy In Mouse Tumor ModelsNational Cancer Institute2002–2005
- Characterization Of The 10q22-23 Candidate Tumor Suppressor In Breast CancerNational Cancer Institute1998–2001
- Colorectal Specific Gene ExpressionNational Cancer Institute1992–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: